Immediate Impact

1 by Nobel laureates 3 from Science/Nature 57 standout
Sub-graph 1 of 25

Citing Papers

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
2024 Standout
2 intermediate papers

Works of Kurt Weigand being referenced

The N-Terminal Propeptide of Collagen Type III in Serum Reflects Activity and Degree of Fibrosis in Patients with Chronic Liver Disease†
1984

Author Peers

Author Last Decade Papers Cites
Kurt Weigand 177 66 33 183 8 365
Andreas Nellen 160 66 28 173 8 402
Iris Albers 134 81 16 141 9 369
Chunlei Fan 129 134 25 159 14 300
P. L. Golding 133 42 6 144 9 374
Jayashree Bagchi Chakraborty 118 94 28 148 5 319
Juan del Olmo 149 98 11 175 11 325
Kentaro Yoshioka 172 85 31 183 15 386
Jin‐Zhong Dong 104 151 10 123 12 345
A Moussouros 206 33 10 249 9 391
Kai Yan Mak 102 64 12 146 9 328

All Works

Loading papers...

Rankless by CCL
2026